MINERALYS THERAPEUTICS, INC. — Operating Income by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/82d0cd58-ed18-4ccb-aef0-c7d99988583e/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-170.6M | 2025-01-01 – 2025-12-31 | evidence 0001933414-26-000056 |
| FY 2024 | $-192.4M | 2024-01-01 – 2024-12-31 | evidence 0001933414-25-000009 |
| FY 2023 | $-84.7M | 2023-01-01 – 2023-12-31 | evidence 0001628280-24-012358 |
| FY 2022 | $-31.5M | 2022-01-01 – 2022-12-31 | evidence 0001628280-24-012358 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).